OR7E53P

Across TCGA pan-cancer cohorts, OR7E53P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR7E53P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR7E53P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E53P expression acts as an unfavorable survival marker, although some lineages such as CESC and COAD show a favorable association.

MESO, CESC, and THCA are the cancer types where OR7E53P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.261	0.393	.007	60	view →
CESC	DFS	Tertile	All	0.966	0.715	.004	36	view →
THCA	DFS	Tertile	II,III,IV	0.121	0.691	<.001	36	view →
ESCA	OS	Median	All	0.546	1.000	.001	27	view →
LGG	OS	Tertile	All	0.663	0.817	.005	18	view →
GBM	DFS	Tertile	All	0.131	0.309	.022	12	view →
COAD	DFS	Tertile	III,IV	1.000	0.336	.018	9	view →
PCPG	DFS	Tertile	All	0.063	0.921	<.001	9	view →
BLCA	OS	Tertile	III,IV	1.000	0.419	.039	6	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.623	.036	6	view →
HNSC	OS	Tertile	IV	0.965	0.709	.024	6	view →
KIRC	OS	Tertile	All	0.499	0.641	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

OR7E53P–MESO (DFS)

Open the MESO breakdown →